Login

BVZ Holding CEO Fernando Lehner on H1 2022, Future Projects, and Motivating His Team Amidst Challenges | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Advancing Brazil's Renewable Energy Market: Challenges and Opportunities | Rogério Pereira Jorge , CEO, AES Brasil Energia SA.
00:10:00
Inflation Trends and Global Economic Insights: Market Week in Review | McKenna Painter
00:10:00
Vulcan Energy Leaders Share Progress on Zero Carbon Lithium™ Phase One | Francis Wedin , CEO, Vulcan Energy Resources Ltd.
00:10:00
Eric Hirsch of Hamilton Lane Discusses Trends and Fed Expectations | Erik Hirsch, CEO, Hamilton Lane.
00:00:00
SkinBioTherapeutics (SBTX) - Stuart Ashman, CEO
00:10:00
Interview with Telos Sr. VP of Technology Solutions, Josh Salmanson, at DOMINO 23.
00:00:00
Brad Thompson CEO of Oncolytics Biotech Inc.
00:10:00
Canada Silver Cobalt Works: Advancing Battery Metals Exploration in Canada
00:10:00
From Skeptic to Systematic: Transforming Company Culture for Growth and Success|CEO, Zenvia Inc
00:10:00
Innovative Healthcare Solutions for Greater Accessibility and Affordability |Ahmed Banderker, CEO, Afrocentric Investment Corporation.
00:10:00
Mastering the Art of Budgeting: Step 3 in 5 Vital Financial Moves | Wakefield Hare - Financial Planner, Greater Than Financial
00:10:00
Koen Dejonckheere on Strategic Investments and Global Technological Trends | Koen Dejonckheere, CEO, GIMV Corporate.

© 2017 - Neuhu+